Under Greater Government Oversight

In a letter to Health and Human Services Secretary Tom Price, independent pharmacists’ group wrote “President Trump’s plans to lower prescription drug costs will only succeed if greater transparency is imposed on pharmacy benefit managers.” Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.